Oncology Xagena
Researchers at the Massachusetts General Hospital ( MGH ) have shown that radiofrequency ablation ( RFA ) a minimally invasive way of destroying tissue is an effective, longlasting treatment for s ...
A study has shown that the immune-stimulating hormone known as Interleukin-12 ( IL-12 ) can safely be administered with Interferon, another immune-system protein, as an experimental therapy for some c ...
Researchers at the Mayo Clinic Cancer Center report that Imatinib ( Glivec, Gleevec ), the drug used to treat patients with gastrointestinal stromal cancers ( GISTs ), is not likely to be effective fo ...
A research has shown that the immune-stimulating hormone known as Interleukin-12 ( IL-12 ) can safely be administered with Interferon, another immune-system protein, as an experimental therapy for som ...
Researchers at UCLA ( University of California - Los Angeles ) knew - based on two clinical trials - that a subset of kidney cancer patients responded well to an experimental targeted therapy, but the ...
A phase II study is assessing the safety and efficacy of Sunitinib ( Sutent ) in patients with advanced non-small cell lung cancer ( NSCLC ) that had progressed following standard therapy. This ...
Researchers at UCLA ( University of California - Los Angeles ) knew - based on two clinical trials - that a subset of kidney cancer patients responded well to an experimental targeted therapy, but the ...
Researchers at UCLA ( University of California - Los Angeles ) knew - based on two clinical trials - that a subset of kidney cancer patients responded well to an experimental targeted therapy, but the ...
Sunitinib ( Sutent ) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma ...
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show Temsirolimus ( Torisel ) improved overall survival when co ...
Sorafenib ( Nexavar ) tablets has significantly extended overall survival in patients with hepatocellular carcinoma ( HCC ), or primary liver cancer versus those taking placebo by 44% ( HR=0.69; p-val ...
Treatment with Everolimus ( Afinitor ) prolongs progression-free survival relative to placebo in patients with metastatic renal cell carcinoma who have experienced treatment failure on other regimens. ...
A study of nearly 1,500 patients treated for kidney cancer at UCLA ( University of California Los Angeles ) in the last 15 years has shown that an aggressive, tailored treatment approach results in b ...
Genetic variations ensure that no two people are exactly alike, nor are their cancers. Researchers now have the tools and the knowledge to predict how individuals will respond to cancer therapy, ena ...
Treatment with Everolimus ( Certican ) prolongs progression-free survival relative to placebo in patients with metastatic kidney cancer ( renal cell carcinoma ) who have experienced treatment failur ...
